Abstract:Background: The brain atrophy in individual Alzheimer's disease (AD) patients includes not only specific atrophy from AD pathology, but also atrophy induced by normal aging and cerebral vascular diseases. Although medial temporal lobe atrophy (MTA) together with CSF biomarkers is suggested to be the most important diagnostic markers for AD, it may not be specific. The current method of choice to measure MTA has been volumetric measurement based on 3D magnetic resonance imaging (MRI), but this complicated method has not been implemented clinically. Female sex has been suggested to be a risk factor for AD. The left hippocampus may be more vulnerable in AD. Atrophy of hippocampus has also been found to emerge in healthy adults, along with increased age. Purposes: To investigate whether simple Computerized Tomography (CT) linear measurements of brain could be of value in AD work-up; to create a normative database of hippocampus volume in our large population-based study and to examine if there is an acceleration of hippocampal atrophy in normal aging; to examine the hippocampal and entorhinal cortex volumes in relation to vascular risk factors. Material and Methods: In the CT study (Papers 1&2), 59 controls, 162 pure AD, and 86 AD with minor cerebrovascular changes (CVC) between the ages of 52 and 94 years were recruited from the Malmo Alzheimer Study. Abeta42, T-tau and P-tau in CSF were examined. CT linear measurements were performed, which included temporal horn ratio and suprasellar cistern ratio that reflect MTA. In the MRI study (Papers 3&4), 544 healthy non-demented subjects (aged 60-97 years) were recruited from the Swedish National study of Aging and Care in Kungsholmen (SNAC-K). Hippocampal formation and entorhinal cortex were manually delineated. Semi-automatic tools were used to access the volume of 3rd, lateral ventricle and intracranial volume (ICV). Vascular risk factors were collected. Results: In the CT study (Papers 1&2), temporal horn ratio and suprasellar cistern ratio were the atrophy factors that contributed most significantly to the diagnoses with correct AD classification of 90.2%. The correct classification of AD+CVC from controls increased from 79.5% (only CSF biomarkers) to 84.6% (combined CT measurements with CSF biomarkers). However, little was changed in the pure AD group. In the MRI study (Papers 3&4), The normalized volumes of hippocampus in males were smaller than that in females. The right hippocampus was larger than the left. The rate of aging atrophy trend (AAT) for the expansion of ventricles was larger than the estimated hippocampal shrinkage. The age point (72y) was shown to represent the time when the acceleration of AAT in hippocampus starts in normal aging. The score of vascular risk factors was significantly associated with reduced volumes of hippocampus and entorhinal cortex only among men. Conclusions: CT linear measurements could be of value in work-up of AD patients. Combined with the CT measure of MTA, the specificity of CSF biomarkers can be increased, but only in AD+CVC. In a non-demented elderly population, the females were more vulnerable to hippocampal atrophy. An acceleration of hippocampal atrophy may emerge and start around 72 years of age. An increasing burden of vascular risk factors is associated with reduced volume of hippocampus and entorhinal cortex.

Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology

Brain imaging evidence of preclinical Alzheimer's disease in normal aging

Acceleration of Brain Atrophy and Progression From Normal Cognition to Mild Cognitive Impairment

Atrophy rates accelerate in amnestic mild cognitive impairment

Accelerating Cortical Thinning: Unique to Dementia or Universal in Aging?

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data From The Alzheimer'S Disease Neuroimaging Initiative Study

P4‐053: Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data from the Alzheimer'S Disease Neuroimaging Initiative Study

P1‐216: Six Month MRI Gray Matter Declines in Alzheimer's Dementia Evaluated by Voxel‐based Morphometry with Multivariate Network Analysis: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative

Longitudinal Trajectory of Amyloid-related Hippocampal Subfield Atrophy in Nondemented Elderly.

Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

IC-03-06: Six Month MRI Gray Matter Declines in Alzheimer's Dementia Evaluated by Voxel-Based Morphometry with Multivariate Network Analysis: Preliminary Findings from the ADNI Study

Early Cortical Microstructural Changes in Aging Are Linked to Vulnerability to Alzheimer's Disease Pathology

Convergent Multimodal Imaging Abnormalities in the Dorsal Precuneus in Subjective Cognitive Decline

Brain MRI and CT Morphology in Healthy Aging and Alzheimer's Disease

Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease for the Alzheimer's Disease Neuroimaging Initiative

Increased Cortical Thickness in Alzheimer's Disease

Morphometric Analysis of Hippocampus and Lateral Ventricle Reveals Regional Difference Between Cognitively Stable and Declining Persons

A Longitudinal Study of Brain Atrophy over Two Years in Community-Dwelling Older Individuals